BlackRock’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

BlackRock’s Portfolio RSLS Stock Details RSLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Hold	0	–	–	–	5121
2018 Q3	–	Hold	0	–	–	–	5128
2018 Q2	–	Sell	-9	Closed	-$7.69K	–	5134
2018 Q1	$29K	Hold	9	–	–	﹤0.01%	4518
2017 Q4	$27K	Buy	+9	New	+$29.8K	﹤0.01%	4524

Other funds holding RSLS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock's RSLS Position: Q4 2018 in Review

BlackRock held its ReShape Lifesciences Inc. Common Stock (RSLS) position steady in Q4 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5121.

BlackRock first reported a position in RSLS in Q4 2017 and has held it in 2 quarters since. The position peaked at $29K in Q1 2018. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

BlackRock held 0 shares of ReShape Lifesciences Inc. Common Stock worth $0 as of Q4 2018.
BlackRock left its ReShape Lifesciences Inc. Common Stock share count unchanged in Q4 2018.
ReShape Lifesciences Inc. Common Stock made up ﹤0.01% of BlackRock's portfolio in Q4 2018, its #5121 holding.
BlackRock first reported a position in ReShape Lifesciences Inc. Common Stock in Q4 2017 and has held it in 2 quarters since.
BlackRock's ReShape Lifesciences Inc. Common Stock position peaked at $29K in Q1 2018.
2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on BlackRock's 13F filing for Q4 2018, filed 8 Feb 2019.